Co-Diagnostics, Inc. (CODX) - Quick Ratio

The price trend for Co-Diagnostics, Inc. (CODX) on GURU.Markets is 1.58. Co-Diagnostics, Inc. (CODX) has modernized its PCR tests via the Co-Primers system, which minimizes diagnostic errors. The business relies on the sale of specialized equipment and reagents, ensuring a steady cash flow and high profitability. Developers are currently implementing rapid testing systems for home use, maintaining a consistent update of their technological portfolio.

CoDx (CODX) Quick Liquidity: for the period 07/04/2022 - 10/29/2026

Summary analytical data breakdowns for codiagnostics.com (CODX)

- market value and analyst target forecast:

Price Chart Co-Diagnostics Corp|CODX - Broker Consensus Forecast

- market capitalization indicators:

Market Capitalization Co-Diagnostics Corp|CODX - Enterprise Value

- balance sheet net asset value indicators:

Net Assets per Single Share Co-Diagnostics|CODX - Company Book Value|Market Cap to Net Assets Ratio codiagnostics.com|CODX - Company Assets

- debt and liquidity data:

- earnings and market multiples details:

CODX - Company Net Income

Analysis of all company metrics:Co-Diagnostics, Inc.

Manufactured product of codiagnostics.com

Production optimization of PCR kits and the reduction of energy intensity across Co-Diagnostics, Inc. (CODX) lines are enhancing operational efficiency, which directly impacts the company's ability to generate liquid assets. An analysis of quarterly quick liquidity demonstrates the capacity to cover short-term liabilities using only cash and accounts receivable, excluding inventory, thereby determining the issuer's real financial stability and investment attractiveness.

Competitors of Co-Diagnostics, Inc. (CODX)